EagleClaw Capital Managment LLC Purchases Shares of 1,089 The Allstate Co. (NYSE:ALL)

EagleClaw Capital Managment LLC acquired a new position in shares of The Allstate Co. (NYSE:ALL) in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 1,089 shares of the insurance provider’s stock, valued at approximately $207,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Northwest Investment Counselors LLC bought a new position in Allstate during the 3rd quarter worth $28,000. Catalyst Capital Advisors LLC acquired a new position in Allstate during the third quarter valued at approximately $29,000. Versant Capital Management Inc raised its stake in Allstate by 70.9% during the second quarter. Versant Capital Management Inc now owns 188 shares of the insurance provider’s stock worth $30,000 after acquiring an additional 78 shares in the last quarter. Family Firm Inc. bought a new position in shares of Allstate in the second quarter worth about $38,000. Finally, MCF Advisors LLC grew its holdings in shares of Allstate by 33.9% during the 2nd quarter. MCF Advisors LLC now owns 332 shares of the insurance provider’s stock valued at $53,000 after purchasing an additional 84 shares during the last quarter. Institutional investors and hedge funds own 76.47% of the company’s stock.

Allstate Stock Up 0.7 %

NYSE:ALL traded up $1.43 during mid-day trading on Wednesday, hitting $198.03. 58,496 shares of the company’s stock were exchanged, compared to its average volume of 1,531,919. The business has a fifty day moving average price of $190.50 and a 200 day moving average price of $177.22. The Allstate Co. has a one year low of $134.17 and a one year high of $201.00. The company has a market cap of $52.44 billion, a PE ratio of 12.73, a P/E/G ratio of 1.76 and a beta of 0.48. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.40 and a quick ratio of 0.40.

Allstate (NYSE:ALL) last announced its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.20 by $1.71. Allstate had a net margin of 6.77% and a return on equity of 26.67%. The company had revenue of $16.63 billion for the quarter, compared to analysts’ expectations of $14.57 billion. During the same quarter in the previous year, the business posted $0.81 EPS. Allstate’s revenue was up 14.7% compared to the same quarter last year. Equities analysts predict that The Allstate Co. will post 16.01 EPS for the current year.

Allstate Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, January 2nd. Shareholders of record on Friday, November 29th will be issued a dividend of $0.92 per share. The ex-dividend date of this dividend is Friday, November 29th. This represents a $3.68 dividend on an annualized basis and a yield of 1.86%. Allstate’s dividend payout ratio is currently 23.83%.

Insider Transactions at Allstate

In related news, insider John E. Dugenske sold 36,367 shares of Allstate stock in a transaction that occurred on Friday, September 20th. The stock was sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the sale, the insider now owns 27,364 shares of the company’s stock, valued at approximately $5,236,922.32. This trade represents a 57.06 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 1.80% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have weighed in on ALL shares. Raymond James boosted their target price on shares of Allstate from $205.00 to $220.00 and gave the stock a “strong-buy” rating in a research note on Friday, October 4th. Morgan Stanley boosted their target price on shares of Allstate from $220.00 to $228.00 and gave the stock an “overweight” rating in a report on Thursday, November 7th. BMO Capital Markets raised their price target on shares of Allstate from $205.00 to $214.00 and gave the company an “outperform” rating in a research note on Friday, October 18th. Wells Fargo & Company boosted their price objective on shares of Allstate from $175.00 to $186.00 and gave the stock an “equal weight” rating in a research note on Tuesday, November 5th. Finally, Piper Sandler raised their target price on Allstate from $188.00 to $196.00 and gave the stock an “overweight” rating in a research report on Friday, August 16th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $214.19.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.